David Weill - 27 May 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
/s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
27 May 2021
Transactions value $
$0
Form type
4
Filing time
01 Jun 2021, 17:23:47 UTC
Next filing
06 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +13.5K $0.00 13.5K 27 May 2021 Common Stock 13.5K $26.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of the first anniversary of the date of grant, May 27, 2022, or the date of the following annual meeting of shareholders of the Company.